Director & CHAIRMAN & CEO
Director & CHAIRMAN & CEO at Kiniksa Pharmaceuticals International, plc, filing insider transactions between 2026-10-30 and 2026-11-03.
| SEC ↗ |
| 2026-11-03 | KNSA | Sale | 68.7K | $92.70 | $6.4M | SEC ↗ |
| 2026-11-02 | KNSA | Sale | 38.4K | $91.03 | $3.5M | SEC ↗ |
| 2026-11-02 | KNSA | Sale | 24.2K | $91.83 | $2.2M | SEC ↗ |
| 2026-11-02 | KNSA | Sale | 26.8K | $93.06 | $2.5M | SEC ↗ |
| 2026-11-02 | KNSA | Sale | 100 | $93.97 | $9K | SEC ↗ |
| 2026-10-30 | KNSA | Sale | 8,888 | $94.72 | $842K | SEC ↗ |
| 2026-10-30 | KNSA | Sale | 15.9K | $93.62 | $1.5M | SEC ↗ |
| 2026-10-30 | KNSA | Sale | 18.7K | $92.77 | $1.7M | SEC ↗ |
| 2026-10-30 | KNSA | Sale | 4,490 | $95.97 | $431K | SEC ↗ |
| 2026-10-30 | KNSA | Sale | 2,316 | $97.34 | $225K | SEC ↗ |
| 2026-10-30 | KNSA | Sale | 1,440 | $98.16 | $141K | SEC ↗ |
| 2026-10-30 | KNSA | Sale | 41.2K | $92.01 | $3.8M | SEC ↗ |